Перевести на Переведено сервисом «Яндекс.Перевод»

Oasmia Pharmaceutical AB

Country
Sweden
Краткое название
Oasmia Pharmaceutical AB
Headquarters
Vallongatan 1
Members of the board

Julian Aleksov,
Chief Executive Officer
Hans Sundin,
Executive Vice President
Weine Nejdemo,
Chief Financial Officer
Annette Ljungmark,
Head of Accounting and Human Resources
Mikael Asp,
Head of Quality Assurance
Ingela Hagglund,
Vice President Operations
Margareta Eriksson,
Vice President Clinical Development
John Cosby,
Head of Regulatory Affairs

Categories medicine
Oncology
Stage of the project
Production
Disease
Blood cancer, Breast cancer, Intestine cancer
Ticker
OASM
Current owners

Joel Citron,
Jan Lundberg,
Martin Nicklasson,
Horst Domdey,
Bo Cederstrand,
Julian Aleksov

Technology
Cell Technologies, Nanotechnology, Pharmaceuticals, Chemistry